Plopii® Migraine Pill — Investigational Paraxanthine + APAP + ASA

The Plopii Migraine Pill is an investigational paraxanthine + acetaminophen + aspirin combination in development under the FDA 505(b)(2) pathway. Patent-pending. Not currently sold as an FDA-approved drug. Learn about our patent filings or the underlying pharmacology.

Plopii® — the paraxanthine energy company from Brooklyn, NY. Science Patents Wholesale FAQ